Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.538
-0.009 (-1.66%)
At close: Mar 9, 2026, 4:00 PM EDT
0.528
-0.010 (-1.91%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Ensysce Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2 | 11 | 3 | 5 | 114 | 18,673 | |
| Market Cap Growth | -73.23% | 218.52% | -30.67% | -95.78% | -99.39% | 21.62% | |
| Enterprise Value | 1 | 7 | 2 | 9 | 112 | - | |
| Last Close Price | 0.55 | 8.14 | 15.90 | 135.00 | 16920.00 | 44764.92 | |
| PE Ratio | - | - | - | - | - | 328929.48 | |
| PS Ratio | 0.42 | 2.04 | 1.50 | 1.91 | 32.28 | 4750.02 | |
| PB Ratio | 1.45 | 3.14 | -5.12 | -1.19 | -13.97 | -2804.46 | |
| P/TBV Ratio | 1.56 | 2.86 | - | - | - | - | |
| EV/Sales Ratio | 0.13 | 1.25 | 0.85 | 3.55 | 31.66 | - | |
| Debt / Equity Ratio | 0.44 | 0.09 | -1.31 | -1.10 | -2.11 | -0.64 | |
| Net Debt / Equity Ratio | -1.47 | -0.95 | 0.41 | -0.32 | -0.61 | -0.61 | |
| Net Debt / EBITDA Ratio | - | - | - | -0.05 | -0.25 | -2.53 | |
| Asset Turnover | 0.71 | 1.25 | 0.52 | 0.23 | 0.42 | 8.06 | |
| Quick Ratio | 0.73 | 1.64 | 0.37 | 0.36 | 0.77 | 0.03 | |
| Current Ratio | 1.27 | 2.42 | 0.69 | 0.56 | 0.95 | 0.05 | |
| Return on Equity (ROE) | -294.39% | -585.41% | - | - | - | - | |
| Return on Assets (ROA) | -109.79% | -101.29% | -155.91% | -135.76% | -148.12% | -206.67% | |
| Return on Capital Employed (ROCE) | -1261.60% | -198.50% | 1715.20% | 676.80% | 30894.50% | 24.20% | |
| Earnings Yield | -583.96% | -75.19% | -318.25% | -502.55% | -25.51% | 0.00% | |
| Buyback Yield / Dilution | -347.04% | -362.24% | -1158.33% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.